← FDA Drug Approvals (Drugs@FDA)
EPOPROSTENOL SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM · Approved 2021-01-15
Drug application
- FDA Application #
ANDA210473- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EPOPROSTENOL SODIUM
- Generic name
- EPOPROSTENOL
- Active ingredients
- EPOPROSTENOL SODIUM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- SUN PHARM
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- First approval
- 2021-01-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown